Vyne Therapeutics: A Heartfelt Announcement of a Private Placement of $88 Million
VYNE Therapeutics Announces Private Placement of $88 Million Embracing Innovation in Clinical Development In a move that has captured the attention of the biopharmaceutical industry, VYNE Therapeutics Inc. has secured a significant private placement of $88 million. This funding will be allocated towards advancing VYNE’s clinical development programs for VYN201 and VYN202 through the end…